Humanigen (STU:0KB1) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Humanigen ROE % Adjusted to Book Value?

Humanigen's ROE % for the quarter that ended in Mar. 2023 was 0.00%. Humanigen's PB Ratio for the quarter that ended in Mar. 2023 was N/A. Humanigen's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was N/A.

Humanigen ROE % Adjusted to Book Value Historical Data

The historical data trend for Humanigen's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen ROE % Adjusted to Book Value Chart

Humanigen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-139.75

Humanigen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	Negative Equity	-

Competitive Comparison of Humanigen's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Humanigen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Humanigen's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Humanigen's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Humanigen's ROE % Adjusted to Book Value falls into.

Humanigen ROE % Adjusted to Book Value Calculation

Humanigen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Humanigen's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Humanigen ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Humanigen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanigen (STU:0KB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (STU:0KB1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078

Website

https://www.humanigen.com

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (STU:0KB1) Headlines

No Headlines